Medical Care
Global Solid-phase Oligonucleotide Synthesis Market Research Report 2025
- Mar 11, 25
- ID: 106028
- Pages: 86
- Figures: 87
- Views: 19
The global market for Solid-phase Oligonucleotide Synthesis was valued at US$ 554 million in the year 2024 and is projected to reach a revised size of US$ 1618 million by 2031, growing at a CAGR of 16.8% during the forecast period.
North American market for Solid-phase Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Solid-phase Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Solid-phase Oligonucleotide Synthesis in Commercial is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Solid-phase Oligonucleotide Synthesis include Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Solid-phase Oligonucleotide Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid-phase Oligonucleotide Synthesis.
The Solid-phase Oligonucleotide Synthesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid-phase Oligonucleotide Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid-phase Oligonucleotide Synthesis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
Segment by Type
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid-phase Oligonucleotide Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Solid-phase Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Solid-phase Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Solid-phase Oligonucleotide Synthesis in Commercial is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Solid-phase Oligonucleotide Synthesis include Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Solid-phase Oligonucleotide Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid-phase Oligonucleotide Synthesis.
The Solid-phase Oligonucleotide Synthesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid-phase Oligonucleotide Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid-phase Oligonucleotide Synthesis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
Segment by Type
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid-phase Oligonucleotide Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Primers
1.2.3 Probes
1.2.4 Intermediate-scale Synthesis Oligos
1.2.5 Large-scale Synthesis Oligos
1.2.6 Linkers and Adaptors
1.3 Market by Application
1.3.1 Global Solid-phase Oligonucleotide Synthesis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid-phase Oligonucleotide Synthesis Market Perspective (2020-2031)
2.2 Global Solid-phase Oligonucleotide Synthesis Growth Trends by Region
2.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Solid-phase Oligonucleotide Synthesis Historic Market Size by Region (2020-2025)
2.2.3 Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2026-2031)
2.3 Solid-phase Oligonucleotide Synthesis Market Dynamics
2.3.1 Solid-phase Oligonucleotide Synthesis Industry Trends
2.3.2 Solid-phase Oligonucleotide Synthesis Market Drivers
2.3.3 Solid-phase Oligonucleotide Synthesis Market Challenges
2.3.4 Solid-phase Oligonucleotide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue
3.1.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue (2020-2025)
3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2020-2025)
3.2 Global Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Solid-phase Oligonucleotide Synthesis Revenue
3.4 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid-phase Oligonucleotide Synthesis Revenue in 2024
3.5 Global Key Players of Solid-phase Oligonucleotide Synthesis Head office and Area Served
3.6 Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
3.7 Global Key Players of Solid-phase Oligonucleotide Synthesis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid-phase Oligonucleotide Synthesis Breakdown Data by Type
4.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Type (2020-2025)
4.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2026-2031)
5 Solid-phase Oligonucleotide Synthesis Breakdown Data by Application
5.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Application (2020-2025)
5.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
6.2 North America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
6.4 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
7.2 Europe Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
7.4 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2020-2025)
8.4 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
9.2 Latin America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
9.4 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
10.4 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Details
11.1.2 Genescript Business Overview
11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Introduction
11.1.4 Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.1.5 Genescript Recent Development
11.2 GeneArt (Thermofischer)
11.2.1 GeneArt (Thermofischer) Company Details
11.2.2 GeneArt (Thermofischer) Business Overview
11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Introduction
11.2.4 GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.2.5 GeneArt (Thermofischer) Recent Development
11.3 Renesas Electronics Corporation
11.3.1 Renesas Electronics Corporation Company Details
11.3.2 Renesas Electronics Corporation Business Overview
11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Introduction
11.3.4 Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.3.5 Renesas Electronics Corporation Recent Development
11.4 DNA 2.0 (ATUM)
11.4.1 DNA 2.0 (ATUM) Company Details
11.4.2 DNA 2.0 (ATUM) Business Overview
11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Introduction
11.4.4 DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.4.5 DNA 2.0 (ATUM) Recent Development
11.5 OriGene
11.5.1 OriGene Company Details
11.5.2 OriGene Business Overview
11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Introduction
11.5.4 OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.5.5 OriGene Recent Development
11.6 BBI
11.6.1 BBI Company Details
11.6.2 BBI Business Overview
11.6.3 BBI Solid-phase Oligonucleotide Synthesis Introduction
11.6.4 BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.6.5 BBI Recent Development
11.7 Genewiz
11.7.1 Genewiz Company Details
11.7.2 Genewiz Business Overview
11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Introduction
11.7.4 Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.7.5 Genewiz Recent Development
11.8 Eurofins Genomics
11.8.1 Eurofins Genomics Company Details
11.8.2 Eurofins Genomics Business Overview
11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Introduction
11.8.4 Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.8.5 Eurofins Genomics Recent Development
11.9 Gene Oracle
11.9.1 Gene Oracle Company Details
11.9.2 Gene Oracle Business Overview
11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Introduction
11.9.4 Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.9.5 Gene Oracle Recent Development
11.10 SBS Genetech
11.10.1 SBS Genetech Company Details
11.10.2 SBS Genetech Business Overview
11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Introduction
11.10.4 SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.10.5 SBS Genetech Recent Development
11.11 Bio Basic
11.11.1 Bio Basic Company Details
11.11.2 Bio Basic Business Overview
11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Introduction
11.11.4 Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.11.5 Bio Basic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Primers
1.2.3 Probes
1.2.4 Intermediate-scale Synthesis Oligos
1.2.5 Large-scale Synthesis Oligos
1.2.6 Linkers and Adaptors
1.3 Market by Application
1.3.1 Global Solid-phase Oligonucleotide Synthesis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid-phase Oligonucleotide Synthesis Market Perspective (2020-2031)
2.2 Global Solid-phase Oligonucleotide Synthesis Growth Trends by Region
2.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Solid-phase Oligonucleotide Synthesis Historic Market Size by Region (2020-2025)
2.2.3 Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2026-2031)
2.3 Solid-phase Oligonucleotide Synthesis Market Dynamics
2.3.1 Solid-phase Oligonucleotide Synthesis Industry Trends
2.3.2 Solid-phase Oligonucleotide Synthesis Market Drivers
2.3.3 Solid-phase Oligonucleotide Synthesis Market Challenges
2.3.4 Solid-phase Oligonucleotide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue
3.1.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue (2020-2025)
3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2020-2025)
3.2 Global Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Solid-phase Oligonucleotide Synthesis Revenue
3.4 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid-phase Oligonucleotide Synthesis Revenue in 2024
3.5 Global Key Players of Solid-phase Oligonucleotide Synthesis Head office and Area Served
3.6 Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
3.7 Global Key Players of Solid-phase Oligonucleotide Synthesis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid-phase Oligonucleotide Synthesis Breakdown Data by Type
4.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Type (2020-2025)
4.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2026-2031)
5 Solid-phase Oligonucleotide Synthesis Breakdown Data by Application
5.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Application (2020-2025)
5.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
6.2 North America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
6.4 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
7.2 Europe Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
7.4 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2020-2025)
8.4 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
9.2 Latin America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
9.4 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
10.4 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Details
11.1.2 Genescript Business Overview
11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Introduction
11.1.4 Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.1.5 Genescript Recent Development
11.2 GeneArt (Thermofischer)
11.2.1 GeneArt (Thermofischer) Company Details
11.2.2 GeneArt (Thermofischer) Business Overview
11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Introduction
11.2.4 GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.2.5 GeneArt (Thermofischer) Recent Development
11.3 Renesas Electronics Corporation
11.3.1 Renesas Electronics Corporation Company Details
11.3.2 Renesas Electronics Corporation Business Overview
11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Introduction
11.3.4 Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.3.5 Renesas Electronics Corporation Recent Development
11.4 DNA 2.0 (ATUM)
11.4.1 DNA 2.0 (ATUM) Company Details
11.4.2 DNA 2.0 (ATUM) Business Overview
11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Introduction
11.4.4 DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.4.5 DNA 2.0 (ATUM) Recent Development
11.5 OriGene
11.5.1 OriGene Company Details
11.5.2 OriGene Business Overview
11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Introduction
11.5.4 OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.5.5 OriGene Recent Development
11.6 BBI
11.6.1 BBI Company Details
11.6.2 BBI Business Overview
11.6.3 BBI Solid-phase Oligonucleotide Synthesis Introduction
11.6.4 BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.6.5 BBI Recent Development
11.7 Genewiz
11.7.1 Genewiz Company Details
11.7.2 Genewiz Business Overview
11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Introduction
11.7.4 Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.7.5 Genewiz Recent Development
11.8 Eurofins Genomics
11.8.1 Eurofins Genomics Company Details
11.8.2 Eurofins Genomics Business Overview
11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Introduction
11.8.4 Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.8.5 Eurofins Genomics Recent Development
11.9 Gene Oracle
11.9.1 Gene Oracle Company Details
11.9.2 Gene Oracle Business Overview
11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Introduction
11.9.4 Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.9.5 Gene Oracle Recent Development
11.10 SBS Genetech
11.10.1 SBS Genetech Company Details
11.10.2 SBS Genetech Business Overview
11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Introduction
11.10.4 SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.10.5 SBS Genetech Recent Development
11.11 Bio Basic
11.11.1 Bio Basic Company Details
11.11.2 Bio Basic Business Overview
11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Introduction
11.11.4 Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.11.5 Bio Basic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Primers
Table 3. Key Players of Probes
Table 4. Key Players of Intermediate-scale Synthesis Oligos
Table 5. Key Players of Large-scale Synthesis Oligos
Table 6. Key Players of Linkers and Adaptors
Table 7. Global Solid-phase Oligonucleotide Synthesis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2020-2025)
Table 11. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2026-2031)
Table 13. Solid-phase Oligonucleotide Synthesis Market Trends
Table 14. Solid-phase Oligonucleotide Synthesis Market Drivers
Table 15. Solid-phase Oligonucleotide Synthesis Market Challenges
Table 16. Solid-phase Oligonucleotide Synthesis Market Restraints
Table 17. Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Solid-phase Oligonucleotide Synthesis Market Share by Players (2020-2025)
Table 19. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2024)
Table 20. Ranking of Global Top Solid-phase Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Solid-phase Oligonucleotide Synthesis, Headquarters and Area Served
Table 23. Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
Table 24. Global Key Players of Solid-phase Oligonucleotide Synthesis, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2020-2025)
Table 28. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2026-2031)
Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2020-2025)
Table 32. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2026-2031)
Table 34. North America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 49. Genescript Company Details
Table 50. Genescript Business Overview
Table 51. Genescript Solid-phase Oligonucleotide Synthesis Product
Table 52. Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 53. Genescript Recent Development
Table 54. GeneArt (Thermofischer) Company Details
Table 55. GeneArt (Thermofischer) Business Overview
Table 56. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product
Table 57. GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 58. GeneArt (Thermofischer) Recent Development
Table 59. Renesas Electronics Corporation Company Details
Table 60. Renesas Electronics Corporation Business Overview
Table 61. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product
Table 62. Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 63. Renesas Electronics Corporation Recent Development
Table 64. DNA 2.0 (ATUM) Company Details
Table 65. DNA 2.0 (ATUM) Business Overview
Table 66. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product
Table 67. DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 68. DNA 2.0 (ATUM) Recent Development
Table 69. OriGene Company Details
Table 70. OriGene Business Overview
Table 71. OriGene Solid-phase Oligonucleotide Synthesis Product
Table 72. OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 73. OriGene Recent Development
Table 74. BBI Company Details
Table 75. BBI Business Overview
Table 76. BBI Solid-phase Oligonucleotide Synthesis Product
Table 77. BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 78. BBI Recent Development
Table 79. Genewiz Company Details
Table 80. Genewiz Business Overview
Table 81. Genewiz Solid-phase Oligonucleotide Synthesis Product
Table 82. Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 83. Genewiz Recent Development
Table 84. Eurofins Genomics Company Details
Table 85. Eurofins Genomics Business Overview
Table 86. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product
Table 87. Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 88. Eurofins Genomics Recent Development
Table 89. Gene Oracle Company Details
Table 90. Gene Oracle Business Overview
Table 91. Gene Oracle Solid-phase Oligonucleotide Synthesis Product
Table 92. Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 93. Gene Oracle Recent Development
Table 94. SBS Genetech Company Details
Table 95. SBS Genetech Business Overview
Table 96. SBS Genetech Solid-phase Oligonucleotide Synthesis Product
Table 97. SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 98. SBS Genetech Recent Development
Table 99. Bio Basic Company Details
Table 100. Bio Basic Business Overview
Table 101. Bio Basic Solid-phase Oligonucleotide Synthesis Product
Table 102. Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 103. Bio Basic Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Solid-phase Oligonucleotide Synthesis Picture
Figure 2. Global Solid-phase Oligonucleotide Synthesis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Solid-phase Oligonucleotide Synthesis Market Share by Type: 2024 VS 2031
Figure 4. Primers Features
Figure 5. Probes Features
Figure 6. Intermediate-scale Synthesis Oligos Features
Figure 7. Large-scale Synthesis Oligos Features
Figure 8. Linkers and Adaptors Features
Figure 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Application: 2024 VS 2031
Figure 11. Commercial Case Studies
Figure 12. Academic Research Case Studies
Figure 13. Solid-phase Oligonucleotide Synthesis Report Years Considered
Figure 14. Global Solid-phase Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Solid-phase Oligonucleotide Synthesis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Solid-phase Oligonucleotide Synthesis Market Share by Region: 2024 VS 2031
Figure 17. Global Solid-phase Oligonucleotide Synthesis Market Share by Players in 2024
Figure 18. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2024
Figure 20. North America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 22. United States Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 26. Germany Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Share by Region (2020-2031)
Figure 34. China Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 42. Mexico Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 46. Turkey Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Genescript Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 50. GeneArt (Thermofischer) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 51. Renesas Electronics Corporation Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 52. DNA 2.0 (ATUM) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 53. OriGene Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 54. BBI Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 55. Genewiz Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 56. Eurofins Genomics Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 57. Gene Oracle Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 58. SBS Genetech Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 59. Bio Basic Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Primers
Table 3. Key Players of Probes
Table 4. Key Players of Intermediate-scale Synthesis Oligos
Table 5. Key Players of Large-scale Synthesis Oligos
Table 6. Key Players of Linkers and Adaptors
Table 7. Global Solid-phase Oligonucleotide Synthesis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2020-2025)
Table 11. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2026-2031)
Table 13. Solid-phase Oligonucleotide Synthesis Market Trends
Table 14. Solid-phase Oligonucleotide Synthesis Market Drivers
Table 15. Solid-phase Oligonucleotide Synthesis Market Challenges
Table 16. Solid-phase Oligonucleotide Synthesis Market Restraints
Table 17. Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Solid-phase Oligonucleotide Synthesis Market Share by Players (2020-2025)
Table 19. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2024)
Table 20. Ranking of Global Top Solid-phase Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Solid-phase Oligonucleotide Synthesis, Headquarters and Area Served
Table 23. Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
Table 24. Global Key Players of Solid-phase Oligonucleotide Synthesis, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2020-2025)
Table 28. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2026-2031)
Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2020-2025)
Table 32. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2026-2031)
Table 34. North America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 49. Genescript Company Details
Table 50. Genescript Business Overview
Table 51. Genescript Solid-phase Oligonucleotide Synthesis Product
Table 52. Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 53. Genescript Recent Development
Table 54. GeneArt (Thermofischer) Company Details
Table 55. GeneArt (Thermofischer) Business Overview
Table 56. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product
Table 57. GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 58. GeneArt (Thermofischer) Recent Development
Table 59. Renesas Electronics Corporation Company Details
Table 60. Renesas Electronics Corporation Business Overview
Table 61. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product
Table 62. Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 63. Renesas Electronics Corporation Recent Development
Table 64. DNA 2.0 (ATUM) Company Details
Table 65. DNA 2.0 (ATUM) Business Overview
Table 66. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product
Table 67. DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 68. DNA 2.0 (ATUM) Recent Development
Table 69. OriGene Company Details
Table 70. OriGene Business Overview
Table 71. OriGene Solid-phase Oligonucleotide Synthesis Product
Table 72. OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 73. OriGene Recent Development
Table 74. BBI Company Details
Table 75. BBI Business Overview
Table 76. BBI Solid-phase Oligonucleotide Synthesis Product
Table 77. BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 78. BBI Recent Development
Table 79. Genewiz Company Details
Table 80. Genewiz Business Overview
Table 81. Genewiz Solid-phase Oligonucleotide Synthesis Product
Table 82. Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 83. Genewiz Recent Development
Table 84. Eurofins Genomics Company Details
Table 85. Eurofins Genomics Business Overview
Table 86. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product
Table 87. Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 88. Eurofins Genomics Recent Development
Table 89. Gene Oracle Company Details
Table 90. Gene Oracle Business Overview
Table 91. Gene Oracle Solid-phase Oligonucleotide Synthesis Product
Table 92. Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 93. Gene Oracle Recent Development
Table 94. SBS Genetech Company Details
Table 95. SBS Genetech Business Overview
Table 96. SBS Genetech Solid-phase Oligonucleotide Synthesis Product
Table 97. SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 98. SBS Genetech Recent Development
Table 99. Bio Basic Company Details
Table 100. Bio Basic Business Overview
Table 101. Bio Basic Solid-phase Oligonucleotide Synthesis Product
Table 102. Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 103. Bio Basic Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Solid-phase Oligonucleotide Synthesis Picture
Figure 2. Global Solid-phase Oligonucleotide Synthesis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Solid-phase Oligonucleotide Synthesis Market Share by Type: 2024 VS 2031
Figure 4. Primers Features
Figure 5. Probes Features
Figure 6. Intermediate-scale Synthesis Oligos Features
Figure 7. Large-scale Synthesis Oligos Features
Figure 8. Linkers and Adaptors Features
Figure 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Application: 2024 VS 2031
Figure 11. Commercial Case Studies
Figure 12. Academic Research Case Studies
Figure 13. Solid-phase Oligonucleotide Synthesis Report Years Considered
Figure 14. Global Solid-phase Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Solid-phase Oligonucleotide Synthesis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Solid-phase Oligonucleotide Synthesis Market Share by Region: 2024 VS 2031
Figure 17. Global Solid-phase Oligonucleotide Synthesis Market Share by Players in 2024
Figure 18. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2024
Figure 20. North America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 22. United States Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 26. Germany Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Share by Region (2020-2031)
Figure 34. China Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 42. Mexico Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 46. Turkey Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Genescript Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 50. GeneArt (Thermofischer) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 51. Renesas Electronics Corporation Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 52. DNA 2.0 (ATUM) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 53. OriGene Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 54. BBI Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 55. Genewiz Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 56. Eurofins Genomics Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 57. Gene Oracle Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 58. SBS Genetech Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 59. Bio Basic Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232